02/05/2026
It’s been a big week of good news for independent pharmacies and for the patients/communities we serve.☺️
👩⚖️After years of investigation, the FTC ruled against Express Scripts for unfair practices costing patients and pharmacies.
🗞️Congress passed PBM reform legislation requiring Medicare Part D plans to reimburse pharmacies at fair and reasonable rates (starting in 2028… yes, we know 😅).
This year, our pharmacy along with 5,600 other independent pharmacies in our group was unable to reach a fair contract with Express Scripts (Cigna, HealthSpring, and related plans).
We’re hopeful that this ruling is a step toward meaningful change and that we’ll be able to serve all patients again next year. 🤞🤞🤞
🚨 More big news from the federal government about PBMs! The Federal Trade Commission today announced a settlement with Cigna's Express Scripts that requires it to eliminate spread pricing, decouple rebates and fees from the list price of drugs, relocate its GPO, Ascent, from Switzerland to the U.S., and submit to FTC monitoring for 10 years. It also forces the company to adopt a cost-plus model for independent pharmacy reimbursement (three pharmacies or fewer) in commercial plans starting in 2027 or sooner.
"I hope this is only the beginning of righting the games leading to higher drug prices and harming competition," says NCPA CEO Douglas Hoey. He adds that "it’s critical that pharmacies are reimbursed at a level that covers their cost of acquiring, dispensing, and monitoring medicines and leaves them with a reasonable profit. The big insurers and their PBMs are notorious for reimbursing pharmacies at rates below their operating costs, which causes them to lose money and ultimately go out of business. We look forward to more details on this element of the agreement.”
⚪ View our full statement: https://bit.ly/4af93pQ
⚪ View the FTC's news release: https://bit.ly/4t8HC9U